Xebra Satisfies Conditions to Licence Unique Water-Soluble Cannabinoid Emulsion IP – Backed by Human Trials
Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
Synopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…
Synopsis: Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it…
Summary : First and only FDA-approved medicine for TED, a serious, progressive, vision-threatening rare disease Clinical improvements were seen as early as…
Summary : Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor…
Synopsis : Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A…
Summary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…
KEYPOINTS: The FDA has granted orphan drug designation (ODD) to CT120 for the treatment of acute lymphoblastic leukemia, a novel chimeric antigen…